ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1068

Analysis of Tweets Containing Information Related to Rheumatological Diseases on Twitter

Adrian abbasi1, Miguel Álvarez-Mon2, Carolina Donat-Vargas3, ana Perez4, julio suarez1, lorena montano1, emilio rico1 and melchor Alvarez de Mon1, 1Hospital Universitario Príncipe de Asturias, Madrid, Spain, 2Hospital Universitario Infanta Leonor, Madrid, Spain, 3IMDEA Food, Cardiovascular and Nutritional Epidemiology Group, Madrid, Spain, 4Hospital Universitario Príncipe de Asturias. Rheumatology. Medicine Faculty. Alcala University Department., Madrid, Spain

Meeting: ACR Convergence 2021

Keywords: education, patient, Emotions, Health Services Research, social media, Social support

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Health Services Research Poster II: Care Models and Innovation (1061–1082)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Twitter is an indicator of the interests of its users in the real world, and therefore, is an appropriate setting to assess the content on rheumatological diseases related tweets. The objective of this research was to analyze the content of the tweets referring to rheumatological diseases.

Methods: We analyzed the content of the tweets published between the 25 of January and 20 February, 2020, in English or Spanish, out of six rheumatological diseases: vasculitis, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren’s syndrome (SS), osteoarthritis (OA) and spondyloartopathies, including spondylitis, ankylosing spondylitis, psoriatic arthritis and reactive arthritis. At least 10% of tweets were randomly selected from each disease. It was classified as medical content (diagnosis, treatment or other aspects of the disease) or non-medical (conversation between users, request for help, etc.). It also has been evaluated the type of user and the suitability of the medical content -appropriate or fake.

Results: 15,250 original tweets were published, selecting 1,628: 1,093 classified as medical, 421 as non-medical and 168 as unclassifiable (Figure 1). We analyzed a total of 1,039 tweets: 1,093 classified as medical and 421 as non-medical.
As shown in Table 1, medical tweets related to RA and OA accounted for 62%, followed by tweets regarding SpA.
Next, we investigated the content of the tweets (Table 1 and Figure 2). Concerning the specific medical contents, it was found that most of the tweets were related to the treatment of the disease (26.5%) followed by information for patients (15.2%). The percentage of tweets with contents referred to the diagnosis, comorbidities and pathophysiology were minor. Within the medical tweets, the content of these varied according to the disease. The specific analysis of the type of medical content among the investigated diseases showed a significative heterogenous distribution (p< 0.001). Contents related to diagnosis were mainly observed in those of vasculitis and SS, and were marginal in those of OA and RA. In contrast, the percentage of treatment related tweets were markedly elevated in those of OA and RA and minimum in those of SS.
Finally, we analyzed the fake content of the tweets (Table 1). Interestingly, a low percentage of tweets with fake content regarding RA, OA and SpA was observed. Furthermore, it was observed that the content of theses fake tweets was mainly focused in the treatment of the diseases. In fact, 5.8 % of the tweets related to treatment showed wrong information. The fake content came from unidentified users. Notably, no fake tweets were encountered among those posted by health professionals or health institutions.

Conclusion: The data show that the interest of Twitter community in rheumatic diseases is high according to the number of tweets. The diseases with more tweets were the most prevalent. Given the interest raised by medical content posted on Twitter, the involvement of health institutions and health care providers in medical related conversations over social media appears to be desirable. However, the content posted by healthcare professionals is always appropriate, although there is some spreading of fake content by unidentified users.

Figure 1. Flowchart illustrating the process followed for the analysis of the tweets, along with the number of tweets included and excluded.

Table 1. Number of tweets with medical contents and of those with fake information related to the rheumatic diseases.

Figure 2. Proportion of the different medical contents among the tweets related to each rheumatic disease.


Disclosures: A. abbasi, None; M. Álvarez-Mon, None; C. Donat-Vargas, None; a. Perez, None; j. suarez, None; l. montano, None; e. rico, None; m. Alvarez de Mon, None.

To cite this abstract in AMA style:

abbasi A, Álvarez-Mon M, Donat-Vargas C, Perez a, suarez j, montano l, rico e, Alvarez de Mon m. Analysis of Tweets Containing Information Related to Rheumatological Diseases on Twitter [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/analysis-of-tweets-containing-information-related-to-rheumatological-diseases-on-twitter/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-tweets-containing-information-related-to-rheumatological-diseases-on-twitter/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology